{"_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgN7ilaYJDA","lastupdate":"2024-09-09T00:00:00.000Z","update_date":"2024-09-09T00:00:00.000Z","lastModified":"May 13, 2025","active":1,"confidence_score":100,"confidence_score_reason":"markets","urlname":"genoox","minimal_profile":null,"status":"Acquired","fullstatus":"Acquired by Qiagen on May, 2025","acquired":0,"hide_reason":null,"hide_reason_data":null,"hide_reasons":[{"id":"8257rxn4P8EFQOmS5hAAauHyYMhhxrA5u6yWX4XUShpybX3AMNo3Y9","reason":"Pending approval - External entity"},{"id":"aOIaOiiqfpA8UMw6VCTh8ueRmkG3lzDy1NGqEOaJbe11OrCzMTCCd6","reason":"The company is a service provider"},{"id":"ddgjKuc3GgH8E5UehSVJviRl471BCajL1plO8HtGoOojy2NivYqQ7x","reason":"Owner asked to delete"},{"id":"EjOKM211H1ira9J63oaGPuUxvr7Oba55TZo3NWsFO5uhbNu7o4x4zD","reason":"The company is not Israeli"},{"id":"J7fQJtnT3GdWWSE3MD8rzaW65LJ4jEIKxSZnneQiReONdZjG3zIqWe","reason":"Owner asked to hide in the meantime"},{"id":"NxlAC3ReFb5ksiYNLp2FnUyluoJzwRCYfcF7xpTZaPM53SdWQ5kv0B","reason":"Pending approval"},{"id":"RhC1tlwXzioK0MfzBII3H2wepEfQOfKVktmdwqeqTJjGi3ZaBWUqZo","reason":"The company is not innovative"},{"id":"S0Ed46vNI6vZYVxLedANWGjas23K6hY0QdsCtiGYL7lshqIEdLV3sA","reason":"The company ceased operations in Israel"},{"id":"VTANq7bEvlsEcPjp0ghelXfShaCosgndONGjgU730aAOxXtaDIF5j3","reason":"This is a product of an existing company"}],"type":"Startup","logokey":"$q06SbfGRXuBHOdhWwCpegWFOmxRUWXimFo2ckl28M9CdKp2yjeC26X","name":"Genoox","oneliner":"Genomic Data Management Platform","registrar":"","website":"https://www.genoox.com/","careerspage":"https://www.genoox.com/careers","founded_month":3,"founded_year":2014,"formernames":[],"sociallinks":{"twitter":"https://twitter.com/GenooxTeam","youtube":"","facebook":"https://www.facebook.com/genoox","linkedin":"https://www.linkedin.com/company/5239418","instagram":""},"social":["https://www.linkedin.com/company/5239418","https://www.facebook.com/genoox","https://twitter.com/GenooxTeam"],"flattenedsociallinks":"https://www.linkedin.com/company/5239418|https://www.facebook.com/genoox|https://twitter.com/GenooxTeam","apps":{"appstore":"","googleplay":""},"is_claimed_by_owner":1,"employees":"51-200","employees_exact":58,"patent":1,"raised":20000000,"stage":"Acquired","public_stage":"Acquired","primary_sector_key":"agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","primary_sector":"Health Tech & Life Sciences","alternativenames":["GNX Data Systems","GNX","Inc"],"about":"Genoox is a healthcare and technology company aiming to make clinical genetic sequencing more accessible. Using the companys cloud-based advanced framework encompassing purpose-built applications, users can easily manage the entire genetic sequencing process and create virtual genetic test modules providing plug-and-play options for the delivery of clinical actionable insights and disease diagnoses.\r\n\r\nDriven by artificial intelligence technology, the companys product, Franklin, integrates data from published literature and publicly available population, disease, and sequence databases and employs machine learning to derive a prediction aggregation score and adjust the weights of ACMG classification criteria.\r\n\r\nGenoox removes the final barrier to widespread adoption of clinical NGS, enabling personalized medicine for mainstream patients. Its platform is used in the diagnosis and treatment of genetic disorders and cancer, as well as new drug discovery and family planning.\r\n\r\nGenoox aims to improve patient outcomes with increased accuracy and efficiency, enabling personalized medicine and patient-specific treatments.","climatetech_description":null,"is_climatetech_relevant":null,"phone":"","country":null,"address":{"israeli":[{"id":"4f4ab437-55a9-4d41-8cde-3a1bdc3b99dd","city":"Tel Aviv-Yafo","type":null,"address":"Tel Aviv-Yafo, Israel","placeid":null,"notactive":0,"openeddate":null,"registrarid":null,"firstrdcenter":0,"registrarname":null}],"officesabroad":[{"id":"34745341-434c-4bb9-acb2-455589ae8da5","city":"Palo Alto","address":"550 California Avenue, Palo Alto, CA, USA","country":"United States","placeid":null},{"id":"cfaa8e64-737a-40d0-92c5-a17f9d8a84d6","city":"New York","address":"New York City, NY, USA","country":"United States","placeid":null}]},"headquarter_address":null,"district":"Center District","news":[{"id":"X6FZgNNeRiFhC7YW3btsx0Ym6SeI7kA4dDWy4vwVwf0MPa6wt53fjL","date":"May 12, 2025","link":"https://www.themarker.com/technation/2025-05-12/ty-article/.premium/00000196-c3e5-dbb0-af9f-cbf7b1f10000","source":"www.themarker.com","visible":1,"analysis":{"tags":"acquisition","round":null,"company":"Genoox","layoffs":null,"summary":"Genoox, an Israeli biomed company specializing in genetic data analysis systems, has been acquired by the Dutch diagnostics company QIAGEN. The acquisition deal is valued at up to $80 million, with an initial payment of $70 million in cash and an additional $10 million contingent upon achieving future milestones. Since its founding in 2014, Genoox has raised $26 million. This acquisition marks a significant growth opportunity for Genoox, allowing it to leverage QIAGENs resources and market reach. The transaction highlights the ongoing consolidation in the biomed sector, particularly in the field of genetic analysis.","partners":null,"customers":null,"eventType":null,"investors":null,"confidence":9,"key_topics":["acquisition","biomed","genetic analysis","investment","milestones"],"date_of_event":"May 12, 2025","product_stage":"released","investment_date":null,"acquired_company":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Acquired-by"],"acquisition_amount":"80 million dollars","FDA approved/pending approval":null,"AI technology developing/using":null,"structuredIssuesShow":"#Acquired-by","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"xbSvpyYCSPN6kumEwxIPtXyEzDcJTWh074qeRWi2saa5WgY9dNszSn","news_summary":"ג'ינוקס, המפתחת מערכת לניתוח מידע גנטי, נמכרת לחברת קיאג'ן ההולנדית בעסקה הכוללת תשלום של 70 מיליון דולר במזומן, ועוד 10 מיליון דולר המותנים בהשגת אבני דרך ■ מאז הקמתה ב-2014 גייסה ג'ינוקס 26 מיליון דולר","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"j8oLd62XfqpS523VSOnHxHUs7jyUFfYNAot8fXrv62hyrzU6okjOqG","date":"Oct 27, 2022","link":"https://www.businesswire.com/news/home/20221026005577/en/Genoox-partners-with-Thermo-Fisher-Scientific-to-automate-cytogenetic-research-data-interpretation-and-reporting-with-AI","source":"www.businesswire.com","visible":1,"analysis":{"entityGrowthIconPath":"none;"},"sentiment":null,"analysisId":"UUxf3LV7swfaVj3eI61TySqKeEatq96BNhzk5SXKPnvUJARvZTnVWW","news_summary":"Genoox partners with Thermo Fisher Scientific to automate cytogenetic research data interpretation and reporting with AI","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"block"},{"id":"9a19f017-72be-4a34-90e5-7037892b2ae7","date":"Mar 1, 2022","link":"https://www.bakersfield.com/ap/news/element-biosciences-partners-with-interpretation-expert-genoox-to-validate-the-aviti-system-for-the-rugd/article_bab109f0-b7cd-5fa3-85cf-19216003dc33.html","source":"www.bakersfield.com","visible":1,"analysis":{"entityGrowthIconPath":"none;"},"sentiment":null,"analysisId":"vNBnNXSeTj3YwwPEj1IFkigJdn7znzsy21dVHe3jyQM9qxqTUVk100","news_summary":"https://www.bakersfield.com/ap/news/element-biosciences-partners-with-interpretation-expert-genoox-to-validate-the-aviti-system-for-the-rugd/article_bab109f0-b7cd-5fa3-85cf-19216003dc33.html","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"block"},{"id":"163e7e66-e06b-4655-ae81-ddd473f9d4f4","date":"Jan 27, 2022","link":"https://www.prnewswire.com/news-releases/genoox-names-andy-page-to-lead-its-advisory-board-301469791.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"healthtech, genomic data platform","company":"Genoox","layoffs":null,"summary":"Genoox, a community-driven genomic data platform, has announced that Andy Page has joined as the leader of its Advisory Board. Pages extensive knowledge and experience in the healthcare industry will help the company scale up quickly. Genooxs platform connects clinicians, genetic counselors, and healthcare organizations, providing a comprehensive analysis of genomic data supported by AI and ML tools. With Pages leadership, the company aims to disrupt the healthcare industry by making curated real-world data instantly accessible and accelerating time to answers for professionals. Genoox has experienced significant growth, with its community of genetic users growing four times over the past year. The company plans to further scale up in 2022 and beyond.","partners":null,"customers":null,"investors":null,"confidence":8,"key_topics":["Advisory Board","Genomic data platform","AI and ML tools","Healthcare industry","Growth strategy"],"date_of_event":"January 27, 2022","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Management Changes"],"acquisition_amount":null,"structuredIssuesShow":"#Management Changes","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"SImawj0FPDmXgmkaqnBXsdnTcQjFXsgmB1Uo5xcyuSIJx9wuRUzNh4","news_summary":"Genoox Names Andy Page to lead its Advisory Board","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"4fe030dd-3dfe-4a33-b5ed-1d9886a74d73","date":"Jun 1, 2021","link":"https://www.prnewswire.com/news-releases/genoox-accelerates-genomic-data-community-platform-expansion-with-8m-round-and-appointment-of-new-board-chair-301301802.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"investment, management changes","company":"Genoox","layoffs":null,"summary":"Genoox, a community-driven genomic data platform, has raised $8 million in a funding round led by IN Venture. The investment will allow the company to expand its community of genetic professional users and enhance the network effect on its platform. Additionally, Ohad Arazi has been appointed as Chairman of the Board. Genoox aims to leverage genomic data to drive the precision medicine revolution and make new clinical discoveries. The companys community of users is rapidly growing and generating valuable insights in various domains. The partnership with Sumitomo Corporation and the addition of Ohad Arazi are expected to further accelerate Genooxs growth and commercialization efforts.","partners":null,"customers":null,"investors":"IN Venture, Sumitomo Corporation, Infinity Medical, Inimiti, Glilot Capital, Triventures","confidence":9,"key_topics":["Genomic data platform","Investment","Expansion","Community-driven","Precision medicine"],"date_of_event":"June 1, 2021","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":"$8 million","structured_issues":["Investment","Management Changes"],"acquisition_amount":null,"structuredIssuesShow":"#Investment  #Management Changes","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"6Oz1ARCJfCh1IEqa3meBiBBem6AcF0ey3OiohKnxnGgKMDXksTbRZK","news_summary":"Genoox accelerates genomic data community platform expansion with $8M round and appointment of new Board Chair","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"56bcc6bd-253a-45c3-a9d4-b9aae4714010","date":"Dec 23, 2020","link":"https://www.pc.co.il/featured/328547/?_atscid=7_134353_204082920_1720576_0_Txtetaxjxdshwhus8sp","source":"www.pc.co.il","visible":1,"analysis":{"tags":"Healthcare, Genomics","company":"Genoox","layoffs":"Not specified","summary":"Israeli start-up Genoox, founded by Amir Trabelsi and Moshe Einhorn in 2014, has developed a system for analyzing DNA to help doctors, clinicians, and researchers implement genetic sequencing results in various medical applications. The company, which raised $6 million in 2018 to expand its team, is working in partnership with the Ministry of Health as part of a national digital health project to monitor and sequence the genome of 100,000 Israeli citizens. Genooxs platform simplifies the management and interpretation of genetic data combined with clinical and historical data on the patient, leading to wider adoption of genomic information in patient care decisions.","partners":"Ministry of Health","customers":"Not specified","investors":"Not specified","confidence":8,"key_topics":["Genomics","Personalized Medicine","Investment","Expansion","Partnership"],"date_of_event":"Not specified","valuation_amount":"Not specified","impact_on_company":"growth-positive","investment_amount":"$6 million","structured_issues":["Investment","Partners","Expand"],"acquisition_amount":"Not specified","structuredIssuesShow":"#Investment  #Partners  #Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"OnsU6YAZT9zIlWbUoiAMnKCXSOFWDiIf9IM0uYapK2BhU96neFcyMo","news_summary":"הסטארט-אפ שמסייע להתאים את הטיפול למבנה הגנטי האישי -","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"5577bcf8-613b-4489-99d2-cb97ad491d40","date":"Mar 31, 2020","link":"https://www.globenewswire.com/news-release/2020/03/31/2009101/0/en/Bionano-Genomics-to-Support-Largest-Study-to-Date-on-COVID-19-Disease-Susceptibility.html","source":"www.globenewswire.com","visible":1,"analysis":{"tags":"genomic study","company":"Bionano Genomics","layoffs":null,"summary":"Bionano Genomics has launched a study to identify genomic variants and novel active substances that influence resistance or sensitivity to the SARS-CoV2 virus. The study involves 1,000 patients and controls and aims to identify genomic variants that affect the disease and immune or metabolic variables that can protect against more severe disease. Bionano Genomics is donating consumables, Rescale and Amazon Web Services are donating compute resources, and Genoox is donating their compute resources for the analysis of genomic variants. The study is part of the global Tech Against Covid initiative. The results will be shared with the medical and research community.","partners":["Rescale","Amazon Web Services","Genoox"],"customers":null,"investors":null,"confidence":8,"key_topics":["genomic variants","COVID-19","study","donations","technology"],"date_of_event":"2020-03-31","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners","Investment"],"acquisition_amount":null,"structuredIssuesShow":"#Partners  #Investment","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"ZE4Ld5wNw4Jlt46BrfJ6r9waGuzHPOG75zOMkOgmMtuSUB271aTMDL","news_summary":"Bionano Genomics to Support Largest Study to Date on COVID-19 Disease Susceptibility","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"21210dff-7dab-4f5b-bb0e-12ee3cd7c5c9","date":"Jan 24, 2019","link":"https://www.prweb.com/releases/genoox_launches_genetic_data_reanalysis_capabilities_to_solve_for_disconnect_between_clinical_evidence_and_application/prweb16050570.htm","source":"www.prweb.com","visible":1,"analysis":{"tags":"healthcare technology","company":"Genoox","layoffs":null,"summary":"Genoox, a healthcare technology company, has announced major updates to its platform. The updates use artificial intelligence-based tools to promote regular genomic data reanalysis and data aggregation, improving diagnoses for patients based on new clinical evidence. The platform can automatically alert customers when genetic samples contain previously unidentified mutations. This eliminates the need for labs to constantly run manual tests. Genoox aims to bridge the technology disconnect between academic literature and real-world applications of NGS. The companys platform is expected to benefit sick patients with unidentified conditions, families seeking answers, and future patients with the same mutations. The collaboration between Genoox and Scripps Research holds promise for advancing science and medicine.","partners":["Scripps Research"],"customers":null,"investors":null,"confidence":9,"key_topics":["Genomic data reanalysis","Artificial intelligence","NGS technology","Clinical evidence","Genetic sequencing"],"date_of_event":"January 24, 2019","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers","Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Customers  #Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"3IlF11sxd9ohUA0vsuYMJwz5V5BjkOHQnsMnJFpEA7hiiZe9vrtFhx","news_summary":"Genoox Launches Genetic Data Reanalysis Capabilities to Solve for Disconnect Between Clinical Evidence and Application","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"6a5e0ea7-24a6-4c1e-b071-943b472a20a9","date":"Oct 17, 2018","link":"https://globenewswire.com/news-release/2018/10/17/1622842/0/en/Bionano-and-Genoox-Launch-Integrated-Platform-for-Identification-of-Structural-Variants-in-DNA.html","source":"globenewswire.com","visible":1,"analysis":{"tags":"Partnership, Product Launch","company":"Bionano Genomics","layoffs":"N/A","summary":"Bionano Genomics and Genoox have announced the launch of the Genoox Integrated Platform for the identification of structural variants. The platform combines Bionanos Saphyr system and Genoox technology to provide sensitive and accurate detection of structural variation and genetic mutations. The platform will help speed up genetic diagnosis by combining raw NGS read data with Bionano-based SV calls from a single patient. The companies will begin to co-sell and co-market the integrated platform immediately.","partners":"Genoox","customers":"N/A","investors":"N/A","confidence":9,"key_topics":["Genoox Integrated Platform","Structural Variants Detection","Genome Analysis","Next-Generation Sequencing","Clinical Genetic Applications"],"date_of_event":"October 17, 2018","valuation_amount":"N/A","impact_on_company":"growth-positive","investment_amount":"N/A","structured_issues":["Partners","Expand"],"acquisition_amount":"N/A","structuredIssuesShow":"#Partners  #Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"zN4G2slPCNLaukzdjZNYHk2nvQdBiUyaUjLD26FAbujlbsyukjRern","news_summary":"Bionano and Genoox Launch Integrated Platform for Identification of Structural Variants in DNA","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"a94ecdd9-348b-46c4-8610-d971890413ba","date":"Oct 15, 2018","link":"https://www.prnewswire.com/news-releases/genoox-and-microsoft-healthcare-partner-to-help-advance-precision-medicine-300730687.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"partnership","company":"Genoox","layoffs":null,"summary":"Genoox has announced a partnership with Microsoft Healthcare to bring Microsoft Genomics service to its global customers. This partnership aims to advance precision medicine by combining Genooxs genetic data translation capabilities with Microsofts Azure cloud and AI technologies. Genoox provides a SaaS platform for developing NGS-based genetic applications, and by integrating Microsoft Genomics pipeline, it will enable rapid analysis and actionable insights for clinicians and researchers. The collaboration is expected to improve patient outcomes and reduce time to market for clinical applications.","partners":["Microsoft Healthcare"],"customers":null,"investors":null,"confidence":9,"key_topics":["Genoox","Microsoft Healthcare","precision medicine","genomics","AI"],"date_of_event":"October 15, 2018","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"nAOmZqagGLJZTahMXkgwgPjQjgiC5GmIaeCvvhnIDfMOBhZzBSrKBp","news_summary":"Genoox and Microsoft Healthcare partner to help advance precision medicine","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"59144d4c-7da4-4376-9a11-656492fb29e6","date":"May 16, 2018","link":"http://www.globes.co.il/en/article-israeli-genomic-analysis-co-genoox-raises-6m-1001236471","source":"www.globes.co.il","visible":1,"analysis":{"tags":"genomic analysis","company":"Genoox","layoffs":null,"summary":"Israeli genomic analysis company Genoox has closed a $6 million financing round led by Triventures. The startup aims to make it easier for doctors, clinicians, and researchers to analyze and act on genetic sequencing results. Genoox employs machine learning algorithms to analyze large amounts of genetic data and is transforming the market by offering broader tests that cover large parts of the genome. The company has partnerships with medical centers and research facilities and has recently partnered with Bionano Genomics to enhance the detection of disease-causing structural variants in DNA.","partners":["Triventures","Inimiti Capital","Glilot Capital Partners"],"customers":null,"investors":["Triventures","Inimiti Capital","Glilot Capital Partners"],"confidence":9,"key_topics":["Genomic analysis","Machine learning algorithms","Partnerships","Personalized medicine","Integrated platform"],"date_of_event":"May 16, 2018","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":"$6 million","structured_issues":["Investment","Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Investment  #Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"7vACT929gjI4LAnmxjtDphlZMT827nx7RRn7sUx46lRtDhoWPyfHN4","news_summary":"Israeli genomic analysis co Genoox raises $6m","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"f074abc6-dfae-46e4-b596-22844469cfdd","date":"Apr 13, 2018","link":"https://www.businesswire.com/news/home/20180413005095/en/Genoox-Collaborates-Bionano-Enhance-Detection-Disease-Causing","source":"www.businesswire.com","visible":1,"analysis":{"entityGrowthIconPath":"none;"},"sentiment":null,"analysisId":"SF1wyZKrbskGySJ0aePfAYZmOLUP8aAqVJeUwUniOKLjIHxbp3oXri","news_summary":"Genoox Collaborates with Bionano to Enhance the Detection of Disease Causing Structural Variants in DNA","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"block"},{"id":"ad07b114-8a47-463f-8081-f8cf77812d5d","date":"Oct 1, 2017","link":"http://www.huffingtonpost.com/entry/the-importance-of-data-governance-in-the-future-of_us_59cf1cbde4b0f58902e5cc5e?lipi=urn%3Ali%3Apage%3Ad_flagship3_company_admin%3BePz7VzMZSt6IyjhNQuu4TA%3D%3D","source":"www.huffingtonpost.com","visible":1,"analysis":{"tags":"Partnership, Expansion, Investment","company":"Genoox","layoffs":"Not specified","summary":"Genoox, a data analytics start-up, has partnered with the 100,000 Israeli Genome Project to analyse genetic data and provide actionable insights to hospitals, clinical labs and researchers throughout Israel. The partnership is part of Genooxs expansion, which was supported by a recent $6m funding round. The company aims to make genetic sequencing more accessible. The article also discusses the importance of robust data governance in healthcare, as the industry becomes more data intensive. It highlights the need for clear legal and ethical principles around consent, especially as more genomic data is generated.","partners":"100,000 Israeli Genome Project","customers":"100,000 Israeli Genome Project","investors":"Not specified","confidence":8,"key_topics":["Genomic Data","Healthcare","Data Analytics","Expansion","Investment"],"date_of_event":"Not specified","valuation_amount":"Not specified","impact_on_company":"Growth-Positive","investment_amount":"$6 million","structured_issues":["Customers","Partners","Investment","Expand"],"acquisition_amount":"Not specified","structuredIssuesShow":"#Customers  #Partners  #Investment  #Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"Growth-Positive","analysisId":"lNslSB8OfP1dpPUscIbL3aNexYa1knohjnLn5dyRp31krgPgV5YJnn","news_summary":"The Importance Of Data Governance In The Future Of Healthcare","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"68028142-f121-4e49-adf8-b6195149baf6","date":"Sep 28, 2017","link":"https://www.genomeweb.com/informatics/genoox-betting-variant-classification-tech-bring-more-ngs-community-hospitals?lipi=urn%3Ali%3Apage%3Ad_flagship3_company_admin%3BePz7VzMZSt6IyjhNQuu4TA%3D%3D","source":"www.genomeweb.com","visible":1,"analysis":{"tags":["genomic analysis","next-generation sequencing","variant classification technology"],"company":"Genoox","layoffs":null,"summary":"Genomic analysis startup Genoox has entered the US market and raised $6 million in a Series A round of private equity investment. The company has developed an AI engine to classify genetic variants based on medical guidelines, with the aim of making next-generation sequencing more accessible to community hospitals and laboratories. Genooxs technology can lower sequencing costs by up to 90% and reduce turnaround time to minutes. The company plans to be an end-to-end supplier, providing data analytics services to integrate genomic sequencing information into clinical workflows. The target market is community hospitals and independent labs, and Genoox aims to address the bottleneck of clinical reporting. The company also plans to expand its platform to analyze germline mutations and focus on rare diseases, childhood disorders, hereditary diseases, and cancers.","partners":null,"customers":null,"investors":"unspecified","confidence":8,"key_topics":["genomic analysis","next-generation sequencing","variant classification","clinical uptake","artificial intelligence"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":"$6 million","structured_issues":["Investment","Expand"],"acquisition_amount":null,"structuredIssuesShow":"#Investment  #Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"6J97hhAhrpvscqNDfotorJhloGu6hVaLT5jT51t5YMlUwkEz0wyAgd","news_summary":"Genoox Betting On Variant Classification Tech to Bring More NGS to Community Hospitals","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"25157452-44fd-4cba-be57-a30d4df69e5f","date":"Jul 11, 2017","link":"https://techcrunch.com/2017/07/11/genoox-raises-6m-to-make-genetic-data-analysis-more-accessible-for-clinics/?ncid=mobilenavtrend","source":"techcrunch.com","visible":1,"analysis":{"tags":"genomic data","company":"Genoox","layoffs":null,"summary":"Genoox, a startup that facilitates the use of genomic data in patient care, has raised $6 million in funding. The funding will be used for the companys expansion into the U.S. Genooxs software is already used by top genetic medicine institutes and labs in Israel, and it was contracted by the Israeli government for a genomic data analysis project. The companys technology uses machine-learning algorithms to analyze rare genetic mutations and predict their probability of causing a condition. Genoox aims to make genetic sequencing more accessible and less time-consuming for clinics. The companys platform can examine data from both whole-genome sequencing and whole-exome sequencing, and it plans to create new applications for genetic testing.","partners":null,"customers":null,"investors":"Inimiti Capital Partners, Glilot Capital Partners","confidence":9,"key_topics":["Genomic data","Funding","Expansion","Machine-learning algorithms","Genetic sequencing"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":"$6 million","structured_issues":["Investment","Expand"],"acquisition_amount":null,"structuredIssuesShow":"#Investment  #Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"h32cpNGEGS6GuyFbOKRzBp5UsqlgAkBTWqQE67jXo9gOXD9sTcoWmU","news_summary":"Genoox raises $6M to make genetic data analysis more accessible for clinics","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"}],"newsNumber":15,"techcommunityinvolvement":null,"mediagallery":[{"id":"4df7c2c3-97c6-443d-80ef-5e1f0bac8d49","timestamp":"2020-07-14 18:22:43.000000","resources_type":2,"resources_title":"","resources_file_name":"_mn-TvJFSDs","alt":"","imageurl":"https://img.youtube.com/vi/_mn-TvJFSDs/0.jpg","url":"http://youtu.be/_mn-TvJFSDs"}],"tags":["clinical-trials","doctors","big-data","genomics","digital-healthcare","data-management","diagnostics","artificial-intelligence","precision-medicine","data-analytics","deep-learning","cloud-based","personalization","healthcare-providers","software-platform","cancer","actionable-insights","pharma-companies","genetic-disorders","machine-learning","drug-discovery","clinics","decision-support","bioconvergence"],"classificationIDs":["agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rJEIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety7cLDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQ4b8IDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1i8MIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18NgJDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NuxioUJDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu81fgLDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah6ILDA"],"technologysuccessstory":null,"usecases":[],"businessmodels":["B2B"],"productstage":"Released","products":["Franklin"],"geomarkets":["South America","United States","Australia","India","Europe","Asia"],"targetmarkets":[],"marketcapital":null,"marketcapitaldate":null,"funding":{"investors":9,"lastfunding":"Undisclosed","totalrounds":6,"fundingstage":"Acquired","totalfunding":"$20M","publicinvestors":9,"lastpublicfunding":0,"totalpublicrounds":6,"totalpublicfunding":20000000},"team":[{"name":"Ohad Arazi","email":"ohad@genoox.com","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICA4LfilrMKDA","bounced":true,"claimed":0,"founder":0,"urlname":"ohad-arazi-1","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgIDgj9OrpggM","position":"Chairman of The Board","last_name":"Arazi","claimtoken":"Ov3aVPOaYvIhsRmZ6bPa9LYh30Thyv4FaPvxengfCjVX94hHMQZ8xv","first_name":"Ohad","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/ohad-arazi-44492293/","unsubscribed":true,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2023-01-10 14:09:14.000000","initials":"OA","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Amir Trabelsi","email":"amir@genoox.com","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgPGyipcIDA","bounced":false,"claimed":1,"founder":0,"urlname":"amir-trabelsi","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICA3pvOoQoM","position":"Co-founder & CEO","last_name":"Trabelsi","claimtoken":"091a24c0e5b7e41fb8943a12c3dbf06eb240ae6c9cfa04d3a7964dc2c626191f","first_name":"Amir","picturekey":"$oLtXVeFqD92JIQ6YFaaHucEeF5LZzdF22l73QTaZ1iNPc3s86LBYWI","claimeddate":"2014-07-30","linkedinurl":"https://www.linkedin.com/pub/amir-trabelsi/1/479/8b7","unsubscribed":false,"is_activeuser":0,"additionalemail":"amirtr@gmail.com","claimedemaildate":null,"initials":"","pictureurl":"https://storage.googleapis.com/clean-finder-353810/$oLtXVeFqD92JIQ6YFaaHucEeF5LZzdF22l73QTaZ1iNPc3s86LBYWI","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Moshe Einhorn","email":"moshe@genoox.com","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgPHZ9dMIDA","bounced":false,"claimed":0,"founder":1,"urlname":"moshe-einhorn","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICAvtW2pQgM","position":"Co-founder & CTO","last_name":"Einhorn","claimtoken":"poLd1yeiq9ZVv9peUNd3TtOVytQi4Q982jNhhoG2McyPvNqOQ53Lrk","first_name":"Moshe","picturekey":"$FwKshTiaObWpPFHvtdb87aIOgqw333PUUG3hQceu2RW2GjUv1HFvqQ","claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/moshe-einhorn-a046602/","unsubscribed":false,"is_activeuser":1,"additionalemail":"moshme@gmail.com","claimedemaildate":"2024-09-09 15:49:52.000000","initials":"","pictureurl":"https://storage.googleapis.com/clean-finder-353810/$FwKshTiaObWpPFHvtdb87aIOgqw333PUUG3hQceu2RW2GjUv1HFvqQ","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Guy Harel","email":"guy@genoox.com","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAoOaT0YsJDA","bounced":false,"claimed":1,"founder":0,"urlname":"guy-harel-6","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICg9p2bmQkM","position":"Head of Business Operations","last_name":"Harel","claimtoken":"b75f7a5841ce3a258700c749c6a7c36221e86d6117cdd7bed3365194ca21b04f","first_name":"Guy","picturekey":"$7c84ywWUgMW2ezO0cUZku4T1tlfFFoai1jri96Q8ueg2M0by1jotWN","claimeddate":"2018-01-14","linkedinurl":"https://www.linkedin.com/in/guyharel/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2018-01-14 09:17:08.000000","initials":"","pictureurl":"https://storage.googleapis.com/clean-finder-353810/$7c84ywWUgMW2ezO0cUZku4T1tlfFFoai1jri96Q8ueg2M0by1jotWN","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""}],"description_edited":1,"tag_line_edited":1,"sector":"Digital Health and Medical Technologies","sectorverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAwPi8kYoKDA","fullname":"Ayelet Beazley"},"biverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgMGgoMMJDA","fullname":"Yanina Wainscheinker"},"biverifydate":"2020-07-14T00:00:00.000Z","crunchbaseid":"genoox","lastupdator":"Yanina Wainscheinker","lastupdator_email":"yanina.wainscheinker@sncentral.org","creator":"Jenny Sotnik-Talisman","creator_email":"genys30@yahoo.com","createdate":"2014-07-29T00:00:00.000Z","biverification":"Yanina Wainscheinker","sectorverification":"Ayelet Beazley","affiliatedOrganizations":null,"timeline":[{"id":"4A2xoIIOXSHHqIDTWRh1a6mPMdATrWRTegJR6qRBcNPMnGog7VDw4g","date":"May 2025","amount":"$80M","source":"https://www.calcalistech.com/ctechnews/article/bywvahyblg","mnatype":"Acquisition","eventtype":"MNAEvent","investment":[],"wasacquired":1,"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":null,"acquiredcompany_mna":"Qiagen","acquiredcompany_mna_id":"WynEbtm0qZQuJGbdG61gjXnZ0g2pxX7t8K0ceM1AuYvQVc5n0fuIia","acquiredcompany_mna_type":"Multinational","acquiredcompany_mna_hidden":true,"acquiredcompany_mna_fullurl":"/mnc_page/qiagen","acquiredcompany_mna_logokey":"$BOJVtsSRWoMdTBcUDBB3CILfRTZAjstFfWGZABqzo1CsZDjXiIy9Z8.jpeg","acquiredcompany_mna_urlname":"/mnc_page/qiagen","acquiredcompany_mna_homepage":"https://www.qiagen.com","style":"","hiddenCompanyTooltip":"","acquiredcompany_mna_logourl":"https://storage.googleapis.com/clean-finder-353810/$BOJVtsSRWoMdTBcUDBB3CILfRTZAjstFfWGZABqzo1CsZDjXiIy9Z8.jpeg","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","exit_label":"EXIT","po_label":"Initial Public Offering","acquireddesc":"Was acquired by","sectionname":"Public Offerings & Exit","amountnumber":80000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"Kfu06FN25a1KeALiJKeEuGGMDBSPXed9aqVtezLVWIOu2yS9HpgFxf","date":"Apr 2024","amount":"Undisclosed","source":"https://artofin.com/we-are-happy-to-announce-our-recent-investment-in-genoox/","eventtype":"FundingRoundEvent","investment":[{"name":"Artofin","type":"Investor","amount":null,"hidden":false,"country":"Thailand","fullurl":"/investor_page/artofin","logokey":"$CXaXr0kAJXjMJsGWmU4SByn6POw5xDep2o7se8bMECNTrYIF5XgbeR.png","tagline":null,"urlname":"/investor_page/artofin","isisraeli":0,"investorid":"W983duFW5NUjO21ihS9NdpKVdMeOZwiUC5hdbsePVqZGeKfdr75CJz","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"sEgiAB600NTEPwzOEklzYyu33Fs1iexxGLS7DHdXeUICIwtwqKjIep","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$CXaXr0kAJXjMJsGWmU4SByn6POw5xDep2o7se8bMECNTrYIF5XgbeR.png","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":null,"fundingvisibility":"Public","fundingtypefundingtype":"Undisclosed Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":null,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCbvIrZCgw","date":"May 2021","amount":"$8M","source":"From Sam Chester, senior associate at IN Venture, https://www.prnewswire.com/news-releases/genoox-accelerates-genomic-data-community-platform-expansion-with-8m-round-and-appointment-of-new-board-chair-301301802.html","eventtype":"FundingRoundEvent","investment":[{"name":"IN Venture","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/in-venture","logokey":"$YmTczGNqy86K5T2yEjggaotNTazpN1DsLp7eYLLdbs8kg9tk0Wj7Ok","tagline":null,"urlname":"/investor_page/in-venture","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4Nbb7ZkLDA","fundingtype":"Corporate VC","leadpartner":null,"investmentid":"da240165-99d2-4115-8156-001d0863a924","fundingsubtype":"Corporate VC","investorislead":1,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$YmTczGNqy86K5T2yEjggaotNTazpN1DsLp7eYLLdbs8kg9tk0Wj7Ok","leadcaption":"Lead ","followupcaption":""},{"name":"Inimiti","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/inimiti","logokey":"$nQs6CD33TbqxYFkyj7Nea7p6ytSW7vttqASQ902S03Fj6eFV5IZpmf","tagline":null,"urlname":"/investor_page/inimiti","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgOXxq5YJDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"457958cb-fbd1-42f2-84f5-812de4ebfd3f","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$nQs6CD33TbqxYFkyj7Nea7p6ytSW7vttqASQ902S03Fj6eFV5IZpmf","leadcaption":"","followupcaption":"Follow on "},{"name":"Glilot Capital Partners","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/glilot-capital-partners","logokey":"$I5cHv22GCaATOQS6tV3iiYrWMw4GxrOt2lMXVYjqde4b4DZCqDxzLb.png","tagline":null,"urlname":"/investor_page/glilot-capital-partners","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgNmSw44JDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"56133ec9-a76a-4413-80ef-6ab4ef67e41f","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$I5cHv22GCaATOQS6tV3iiYrWMw4GxrOt2lMXVYjqde4b4DZCqDxzLb.png","leadcaption":"","followupcaption":"Follow on "},{"name":"Infinity Medical","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/i-i-m-infinity-innonation-medical","logokey":"$Z03yp1TS36ifKIQ9nRVBXfjtWMmKKRFjF07Fb9EoFZWe4LBvrs7pLZ","tagline":null,"urlname":"/investor_page/i-i-m-infinity-innonation-medical","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4PPn2p4KDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"aa8afcbc-1336-4692-9ceb-7a333661a851","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$Z03yp1TS36ifKIQ9nRVBXfjtWMmKKRFjF07Fb9EoFZWe4LBvrs7pLZ","leadcaption":"","followupcaption":""},{"name":"Triventures","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/triventures","logokey":"$dzsYbSrKJgvPvZBbbhpoltTv6B2WRBi4fCaQ7HOyP0c9HhBg7OFO8N","tagline":null,"urlname":"/investor_page/triventures","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgJHdj50LDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"ab95537b-459a-495a-9423-4b5fbbe327ff","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$dzsYbSrKJgvPvZBbbhpoltTv6B2WRBi4fCaQ7HOyP0c9HhBg7OFO8N","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"B Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":8000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCEv6DjCQw","date":"May 2018","amount":"$6M","source":"Migrated","eventtype":"FundingRoundEvent","investment":[{"name":"Glilot Capital Partners","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/glilot-capital-partners","logokey":"$I5cHv22GCaATOQS6tV3iiYrWMw4GxrOt2lMXVYjqde4b4DZCqDxzLb.png","tagline":null,"urlname":"/investor_page/glilot-capital-partners","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgNmSw44JDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"PnSlKDYnhp557DX2i9KTdPgAq7EpVm2H7G8woZlkzWX54rFCAtUYuC","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":null,"leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$I5cHv22GCaATOQS6tV3iiYrWMw4GxrOt2lMXVYjqde4b4DZCqDxzLb.png","leadcaption":"","followupcaption":"Follow on "},{"name":"Initial Capital","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/initial-capital","logokey":"$aN6WeJZ1r11q9fvyzI9WONT2JLgXsyYzhF6lWFaPrOLMcpshBdnO3u","tagline":null,"urlname":"/investor_page/initial-capital","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgOXi1YEJDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"uR6afo05tLbHYQzgSSbBiUOBfXvi3pWVU871knT1SrSTaDW7x7KfdL","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":null,"leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$aN6WeJZ1r11q9fvyzI9WONT2JLgXsyYzhF6lWFaPrOLMcpshBdnO3u","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"B Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":6000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCEvPOUCww","date":"Jul 2017","amount":"$6M","source":"Migrated","eventtype":"FundingRoundEvent","investment":[{"name":"Glilot Capital Partners","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/glilot-capital-partners","logokey":"$I5cHv22GCaATOQS6tV3iiYrWMw4GxrOt2lMXVYjqde4b4DZCqDxzLb.png","tagline":null,"urlname":"/investor_page/glilot-capital-partners","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgNmSw44JDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"89c087f6-153f-4e18-9236-2aa08b311a02","fundingsubtype":"VC and Private Equity","investorislead":null,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$I5cHv22GCaATOQS6tV3iiYrWMw4GxrOt2lMXVYjqde4b4DZCqDxzLb.png","leadcaption":"","followupcaption":""},{"name":"Inimiti","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/inimiti","logokey":"$nQs6CD33TbqxYFkyj7Nea7p6ytSW7vttqASQ902S03Fj6eFV5IZpmf","tagline":null,"urlname":"/investor_page/inimiti","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgOXxq5YJDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"bc5ce0d3-16b7-42da-93ac-b66dfd11e2ef","fundingsubtype":"VC and Private Equity","investorislead":null,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$nQs6CD33TbqxYFkyj7Nea7p6ytSW7vttqASQ902S03Fj6eFV5IZpmf","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"A Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":6000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCk2tCACAw","date":"Mar 2016","amount":"Undisclosed","source":"Migrated","eventtype":"FundingRoundEvent","investment":[{"name":"Microsoft Accelerator Tel Aviv","type":"Accelerator","amount":0,"hidden":true,"country":"United States","fullurl":"/program_page/microsoft-accelerator-tel-aviv","logokey":"$BnZGbcjZDTiv5Yvze5tNow0uQUETGM0LFaVqJeJI6AS82ZH3jPSyiQ","tagline":"","urlname":"/program_page/microsoft-accelerator-tel-aviv","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgODE7LeFCQw","fundingtype":"General","leadpartner":null,"investmentid":"fc683b90-c946-47c0-ad0b-e515b9c0efc3","fundingsubtype":"General","investorislead":null,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$BnZGbcjZDTiv5Yvze5tNow0uQUETGM0LFaVqJeJI6AS82ZH3jPSyiQ","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Undisclosed Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":0,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODEu8r1Cww","date":"Aug 2014","amount":"Undisclosed","source":"Migrated","eventtype":"FundingRoundEvent","investment":[{"name":"UpWest","type":"Investor","amount":0,"hidden":false,"country":"United States","fullurl":"/investor_page/upwest-labs","logokey":"$s0XAUrfWJ8AkEG2jvuoMNi3v5uSSaB5mGvWI9XfCJHo96dnh8zGPfY","tagline":null,"urlname":"/investor_page/upwest-labs","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoKWt7LsKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"f775807d-af8e-4b21-bce3-41d39791d073","fundingsubtype":"VC and Private Equity","investorislead":null,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$s0XAUrfWJ8AkEG2jvuoMNi3v5uSSaB5mGvWI9XfCJHo96dnh8zGPfY","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Seed","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":0,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"investmentstage":[],"exits":[],"investments":[],"portfolio":[],"funds":[],"founded":"3/2014","databases":[],"sharedspaces":[],"utilities":[],"contributors":[],"employeesworldwide":"","fundingtype":"Startup","parsedName":"Genoox","logourl":"https://storage.googleapis.com/clean-finder-353810/$q06SbfGRXuBHOdhWwCpegWFOmxRUWXimFo2ckl28M9CdKp2yjeC26X","oglogourl":"https://storage.googleapis.com/clean-finder-353810/$q06SbfGRXuBHOdhWwCpegWFOmxRUWXimFo2ckl28M9CdKp2yjeC26X","seoabout":"Genoox is a healthcare and technology company aiming to make clinical genetic sequencing more accessible. Using the companys cloud-based advanced framework...","seoTitle":"Israeli Startup","solutions":[],"teamMembersNumber":4,"primarySector":"Health Tech & Life Sciences","primary-sector-display":"block","classifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Digital Healthcare","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah6ILDA","classificationName":"sectorclassification"},{"depth":3,"name":"Medical Decision Support","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety7cLDA","classificationName":"sectorclassification"},{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Artificial Intelligence","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rJEIDA","classificationName":"coretechnology"},{"depth":2,"name":"Machine Learning","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu81fgLDA","classificationName":"coretechnology"},{"depth":1,"name":"Data Storage","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQ4b8IDA","classificationName":"coretechnology"},{"depth":2,"name":"Cloud","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18NgJDA","classificationName":"coretechnology"},{"depth":1,"name":"Platforms & Interfaces","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NuxioUJDA","classificationName":"coretechnology"},{"depth":2,"name":"Software","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1i8MIDA","classificationName":"coretechnology"},{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Healthcare","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","classificationName":"targetcustomer"},{"depth":3,"name":"Providers","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","classificationName":"targetcustomer"},{"depth":2,"name":"Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","classificationName":"targetcustomer"},{"depth":3,"name":"Pharmaceuticals","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA","classificationName":"targetcustomer"}],"classificationDelimited":["SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","TechnologyClassificationModel>Artificial Intelligence#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rJEIDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Digital Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah6ILDA>Medical Decision Support#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety7cLDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA>Providers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","TechnologyClassificationModel>Data Storage#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQ4b8IDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA>Pharmaceuticals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA","TechnologyClassificationModel>Platforms & Interfaces#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NuxioUJDA>Software#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1i8MIDA","TechnologyClassificationModel>Data Storage#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQ4b8IDA>Cloud#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18NgJDA","TechnologyClassificationModel>Platforms & Interfaces#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NuxioUJDA","TechnologyClassificationModel>Artificial Intelligence#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rJEIDA>Machine Learning#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu81fgLDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Digital Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah6ILDA"],"classificationsViewModel":"|0:>SectorClassificationModel|1:>SectorClassificationModel/Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA|2:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA/Digital Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah6ILDA|3:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Digital Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah6ILDA/Medical Decision Support#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety7cLDA|0:>IndustryClassificationModel|1:>IndustryClassificationModel/Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA|2:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA/Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA|3:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA/Providers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA|2:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA/Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA|3:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA/Pharmaceuticals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA|0:>TechnologyClassificationModel|1:>TechnologyClassificationModel/Artificial Intelligence#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rJEIDA|2:>TechnologyClassificationModel>Artificial Intelligence#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rJEIDA/Machine Learning#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu81fgLDA|1:>TechnologyClassificationModel/Data Storage#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQ4b8IDA|2:>TechnologyClassificationModel>Data Storage#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQ4b8IDA/Cloud#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18NgJDA|1:>TechnologyClassificationModel/Platforms & Interfaces#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NuxioUJDA|2:>TechnologyClassificationModel>Platforms & Interfaces#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NuxioUJDA/Software#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1i8MIDA|","classificationTrees":{"sector":[{"title":"Health Tech & Life Sciences","key":"0-0","path":"SectorClassificationModel>Health Tech & Life Sciences","children":[{"title":"Digital Healthcare","key":"0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Digital Healthcare","children":[{"title":"Medical Decision Support","key":"0-0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Digital Healthcare>Medical Decision Support"}]}]}],"targetCustomer":[{"title":"Healthcare & Life Sciences","key":"0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences","children":[{"title":"Healthcare","key":"0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare","children":[{"title":"Providers","key":"0-0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare>Providers"}]},{"title":"Life Sciences","key":"0-0-1","path":"IndustryClassificationModel>Healthcare & Life Sciences>Life Sciences","children":[{"title":"Pharmaceuticals","key":"0-0-1-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Life Sciences>Pharmaceuticals"}]}]}],"coreTechnology":[{"title":"Artificial Intelligence","key":"0-0","path":"TechnologyClassificationModel>Artificial Intelligence","children":[{"title":"Machine Learning","key":"0-0-0","path":"TechnologyClassificationModel>Artificial Intelligence>Machine Learning"}]},{"title":"Data Storage","key":"0-1","path":"TechnologyClassificationModel>Data Storage","children":[{"title":"Cloud","key":"0-1-0","path":"TechnologyClassificationModel>Data Storage>Cloud"}]},{"title":"Platforms & Interfaces","key":"0-2","path":"TechnologyClassificationModel>Platforms & Interfaces","children":[{"title":"Software","key":"0-2-0","path":"TechnologyClassificationModel>Platforms & Interfaces>Software"}]}]},"sectorClassifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Digital Healthcare","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah6ILDA","classificationName":"sectorclassification"},{"depth":3,"name":"Medical Decision Support","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety7cLDA","classificationName":"sectorclassification"}],"coreTechnologyClassifications":[{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Artificial Intelligence","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rJEIDA","classificationName":"coretechnology"},{"depth":2,"name":"Machine Learning","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu81fgLDA","classificationName":"coretechnology"},{"depth":1,"name":"Data Storage","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQ4b8IDA","classificationName":"coretechnology"},{"depth":2,"name":"Cloud","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18NgJDA","classificationName":"coretechnology"},{"depth":1,"name":"Platforms & Interfaces","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NuxioUJDA","classificationName":"coretechnology"},{"depth":2,"name":"Software","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1i8MIDA","classificationName":"coretechnology"}],"targetCustomerClassifications":[{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Healthcare","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","classificationName":"targetcustomer"},{"depth":3,"name":"Providers","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","classificationName":"targetcustomer"},{"depth":2,"name":"Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","classificationName":"targetcustomer"},{"depth":3,"name":"Pharmaceuticals","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA","classificationName":"targetcustomer"}],"classificationNames":{"sector":["Health Tech & Life Sciences","Digital Healthcare","Medical Decision Support"],"coreTechnology":["Artificial Intelligence","Machine Learning","Data Storage","Cloud","Platforms & Interfaces","Software"],"targetCustomer":["Healthcare & Life Sciences","Healthcare","Providers","Life Sciences","Pharmaceuticals"]},"section":null,"sectionParams":"","queryParams":"","popup_claim_profile":"false","claimedBadge":"inline","display":{"mainContact":"none","climateTag":"none","seeMoreSimilarCompanisDisplay":"none","similarCompaniesTitleFontSize":"3.2rem","similarCompaniesTitle":"Similar Companies","similar_companies":[]},"mainContact":{},"_eventview":{"publicoffering_exit":[{"id":"4A2xoIIOXSHHqIDTWRh1a6mPMdATrWRTegJR6qRBcNPMnGog7VDw4g","date":"May 2025","amount":"$80M","source":"https://www.calcalistech.com/ctechnews/article/bywvahyblg","mnatype":"Acquisition","eventtype":"MNAEvent","investment":[],"wasacquired":1,"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":null,"acquiredcompany_mna":"Qiagen","acquiredcompany_mna_id":"WynEbtm0qZQuJGbdG61gjXnZ0g2pxX7t8K0ceM1AuYvQVc5n0fuIia","acquiredcompany_mna_type":"Multinational","acquiredcompany_mna_hidden":true,"acquiredcompany_mna_fullurl":"/mnc_page/qiagen","acquiredcompany_mna_logokey":"$BOJVtsSRWoMdTBcUDBB3CILfRTZAjstFfWGZABqzo1CsZDjXiIy9Z8.jpeg","acquiredcompany_mna_urlname":"/mnc_page/qiagen","acquiredcompany_mna_homepage":"https://www.qiagen.com","style":"","hiddenCompanyTooltip":"","acquiredcompany_mna_logourl":"https://storage.googleapis.com/clean-finder-353810/$BOJVtsSRWoMdTBcUDBB3CILfRTZAjstFfWGZABqzo1CsZDjXiIy9Z8.jpeg","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","exit_label":"EXIT","po_label":"Initial Public Offering","acquireddesc":"Was acquired by","sectionname":"Public Offerings & Exit","amountnumber":80000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"privateequityfunding":[{"id":"Kfu06FN25a1KeALiJKeEuGGMDBSPXed9aqVtezLVWIOu2yS9HpgFxf","date":"Apr 2024","amount":"Undisclosed","source":"https://artofin.com/we-are-happy-to-announce-our-recent-investment-in-genoox/","eventtype":"FundingRoundEvent","investment":[{"name":"Artofin","type":"Investor","amount":null,"hidden":false,"country":"Thailand","fullurl":"/investor_page/artofin","logokey":"$CXaXr0kAJXjMJsGWmU4SByn6POw5xDep2o7se8bMECNTrYIF5XgbeR.png","tagline":null,"urlname":"/investor_page/artofin","isisraeli":0,"investorid":"W983duFW5NUjO21ihS9NdpKVdMeOZwiUC5hdbsePVqZGeKfdr75CJz","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"sEgiAB600NTEPwzOEklzYyu33Fs1iexxGLS7DHdXeUICIwtwqKjIep","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$CXaXr0kAJXjMJsGWmU4SByn6POw5xDep2o7se8bMECNTrYIF5XgbeR.png","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":null,"fundingvisibility":"Public","fundingtypefundingtype":"Undisclosed Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":null,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCbvIrZCgw","date":"May 2021","amount":"$8M","source":"From Sam Chester, senior associate at IN Venture, https://www.prnewswire.com/news-releases/genoox-accelerates-genomic-data-community-platform-expansion-with-8m-round-and-appointment-of-new-board-chair-301301802.html","eventtype":"FundingRoundEvent","investment":[{"name":"IN Venture","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/in-venture","logokey":"$YmTczGNqy86K5T2yEjggaotNTazpN1DsLp7eYLLdbs8kg9tk0Wj7Ok","tagline":null,"urlname":"/investor_page/in-venture","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4Nbb7ZkLDA","fundingtype":"Corporate VC","leadpartner":null,"investmentid":"da240165-99d2-4115-8156-001d0863a924","fundingsubtype":"Corporate VC","investorislead":1,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$YmTczGNqy86K5T2yEjggaotNTazpN1DsLp7eYLLdbs8kg9tk0Wj7Ok","leadcaption":"Lead ","followupcaption":""},{"name":"Inimiti","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/inimiti","logokey":"$nQs6CD33TbqxYFkyj7Nea7p6ytSW7vttqASQ902S03Fj6eFV5IZpmf","tagline":null,"urlname":"/investor_page/inimiti","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgOXxq5YJDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"457958cb-fbd1-42f2-84f5-812de4ebfd3f","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$nQs6CD33TbqxYFkyj7Nea7p6ytSW7vttqASQ902S03Fj6eFV5IZpmf","leadcaption":"","followupcaption":"Follow on "},{"name":"Glilot Capital Partners","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/glilot-capital-partners","logokey":"$I5cHv22GCaATOQS6tV3iiYrWMw4GxrOt2lMXVYjqde4b4DZCqDxzLb.png","tagline":null,"urlname":"/investor_page/glilot-capital-partners","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgNmSw44JDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"56133ec9-a76a-4413-80ef-6ab4ef67e41f","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$I5cHv22GCaATOQS6tV3iiYrWMw4GxrOt2lMXVYjqde4b4DZCqDxzLb.png","leadcaption":"","followupcaption":"Follow on "},{"name":"Infinity Medical","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/i-i-m-infinity-innonation-medical","logokey":"$Z03yp1TS36ifKIQ9nRVBXfjtWMmKKRFjF07Fb9EoFZWe4LBvrs7pLZ","tagline":null,"urlname":"/investor_page/i-i-m-infinity-innonation-medical","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4PPn2p4KDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"aa8afcbc-1336-4692-9ceb-7a333661a851","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$Z03yp1TS36ifKIQ9nRVBXfjtWMmKKRFjF07Fb9EoFZWe4LBvrs7pLZ","leadcaption":"","followupcaption":""},{"name":"Triventures","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/triventures","logokey":"$dzsYbSrKJgvPvZBbbhpoltTv6B2WRBi4fCaQ7HOyP0c9HhBg7OFO8N","tagline":null,"urlname":"/investor_page/triventures","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgJHdj50LDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"ab95537b-459a-495a-9423-4b5fbbe327ff","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$dzsYbSrKJgvPvZBbbhpoltTv6B2WRBi4fCaQ7HOyP0c9HhBg7OFO8N","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"B Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":8000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCEv6DjCQw","date":"May 2018","amount":"$6M","source":"Migrated","eventtype":"FundingRoundEvent","investment":[{"name":"Glilot Capital Partners","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/glilot-capital-partners","logokey":"$I5cHv22GCaATOQS6tV3iiYrWMw4GxrOt2lMXVYjqde4b4DZCqDxzLb.png","tagline":null,"urlname":"/investor_page/glilot-capital-partners","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgNmSw44JDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"PnSlKDYnhp557DX2i9KTdPgAq7EpVm2H7G8woZlkzWX54rFCAtUYuC","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":null,"leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$I5cHv22GCaATOQS6tV3iiYrWMw4GxrOt2lMXVYjqde4b4DZCqDxzLb.png","leadcaption":"","followupcaption":"Follow on "},{"name":"Initial Capital","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/initial-capital","logokey":"$aN6WeJZ1r11q9fvyzI9WONT2JLgXsyYzhF6lWFaPrOLMcpshBdnO3u","tagline":null,"urlname":"/investor_page/initial-capital","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgOXi1YEJDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"uR6afo05tLbHYQzgSSbBiUOBfXvi3pWVU871knT1SrSTaDW7x7KfdL","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":null,"leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$aN6WeJZ1r11q9fvyzI9WONT2JLgXsyYzhF6lWFaPrOLMcpshBdnO3u","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"B Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":6000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCEvPOUCww","date":"Jul 2017","amount":"$6M","source":"Migrated","eventtype":"FundingRoundEvent","investment":[{"name":"Glilot Capital Partners","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/glilot-capital-partners","logokey":"$I5cHv22GCaATOQS6tV3iiYrWMw4GxrOt2lMXVYjqde4b4DZCqDxzLb.png","tagline":null,"urlname":"/investor_page/glilot-capital-partners","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgNmSw44JDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"89c087f6-153f-4e18-9236-2aa08b311a02","fundingsubtype":"VC and Private Equity","investorislead":null,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$I5cHv22GCaATOQS6tV3iiYrWMw4GxrOt2lMXVYjqde4b4DZCqDxzLb.png","leadcaption":"","followupcaption":""},{"name":"Inimiti","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/inimiti","logokey":"$nQs6CD33TbqxYFkyj7Nea7p6ytSW7vttqASQ902S03Fj6eFV5IZpmf","tagline":null,"urlname":"/investor_page/inimiti","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgOXxq5YJDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"bc5ce0d3-16b7-42da-93ac-b66dfd11e2ef","fundingsubtype":"VC and Private Equity","investorislead":null,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$nQs6CD33TbqxYFkyj7Nea7p6ytSW7vttqASQ902S03Fj6eFV5IZpmf","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"A Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":6000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCk2tCACAw","date":"Mar 2016","amount":"Undisclosed","source":"Migrated","eventtype":"FundingRoundEvent","investment":[{"name":"Microsoft Accelerator Tel Aviv","type":"Accelerator","amount":0,"hidden":true,"country":"United States","fullurl":"/program_page/microsoft-accelerator-tel-aviv","logokey":"$BnZGbcjZDTiv5Yvze5tNow0uQUETGM0LFaVqJeJI6AS82ZH3jPSyiQ","tagline":"","urlname":"/program_page/microsoft-accelerator-tel-aviv","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgODE7LeFCQw","fundingtype":"General","leadpartner":null,"investmentid":"fc683b90-c946-47c0-ad0b-e515b9c0efc3","fundingsubtype":"General","investorislead":null,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$BnZGbcjZDTiv5Yvze5tNow0uQUETGM0LFaVqJeJI6AS82ZH3jPSyiQ","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Undisclosed Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":0,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODEu8r1Cww","date":"Aug 2014","amount":"Undisclosed","source":"Migrated","eventtype":"FundingRoundEvent","investment":[{"name":"UpWest","type":"Investor","amount":0,"hidden":false,"country":"United States","fullurl":"/investor_page/upwest-labs","logokey":"$s0XAUrfWJ8AkEG2jvuoMNi3v5uSSaB5mGvWI9XfCJHo96dnh8zGPfY","tagline":null,"urlname":"/investor_page/upwest-labs","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoKWt7LsKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"f775807d-af8e-4b21-bce3-41d39791d073","fundingsubtype":"VC and Private Equity","investorislead":null,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$s0XAUrfWJ8AkEG2jvuoMNi3v5uSSaB5mGvWI9XfCJHo96dnh8zGPfY","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Seed","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":0,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"nonequityfunding":[],"merger_acquisitions":[],"others":[]}}